Cholesterol screening method and device

Abstract

The embodiment of the invention provides a cholesterol screening method and device. The cholesterol screening method comprises the steps of firstly estimating cardiovascular disease attach risk of a user initially according to a hypothetical cholesterol value and other cardiovascular disease hazard information of the user, measuring an actual cholesterol value of the user when the initially-estimated risk is larger than the standard or the threshold suitable for beginning medicine prevention, estimating the actual cardiovascular disease attack risk of the user according to the actual cholesterol value, and finally deciding whether the user is suggested to take medicine prevention according to whether the actual risk is larger than the standard or the threshold suitable for beginning medicine prevention. The cholesterol screening method can guarantee low omission factor and the total prevention effect, can avoid cholesterol measurement of all the people and saves more than 80% of cholesterol measurement cost for the society. In the individual level, the cholesterol screening method can avoid unnecessary cholesterol measurement and follow-up side effects of misdiagnosis, emotional stress, work delay, study delay and the like caused by screening.

Description

Technical field [0001] The invention relates to the field of primary prevention of cardiovascular diseases, in particular to a cholesterol screening method and equipment. Background technique [0002] Cardiovascular disease has become the largest burden of disease for human beings, and it is also an important reason for the rising health costs. The morbidity and mortality of cardiovascular diseases in my country are increasing rapidly. Since 1990, the proportion of cardiovascular disease deaths in my country has continued to occupy the first place in the total death toll, and it has been close to 40% of the total death toll in the country in recent years. Drug prevention is one of the important measures for the primary prevention of cardiovascular disease. Combining multiple drugs can reduce cardiovascular events by more than 80%. Whether a person can benefit from drug prevention and the primary determinant of the size of the benefit is the overall risk of cardiovascular d...

AI Technical Summary

Problems solved by technology

[0006] However, this method has the following problems: first, the sensitivity is only about 70%, that is, only 70% of high-risk individuals who need drug prevention can be correctly screened out, and the remaining 30% will be missed; second, the measurement of overall cardiovascular disease The cholesterol of the 20% people with the highest risk is an artificial regulation, which is not applicable to other populations or different decision-making situations, and when there is no data support from the actual population, the missed detection rate and the reduced number of cholesterol measurements cannot be determined; Third, more importantly, in the absence of information on the cardiovascular risk factors of each individual in the overall population, this method cannot rank the overall risk of cardiovascular disease to select the 20% of people with the highest risk, resulting in This method cannot be used, therefore, this method is currently not feasible in rural areas and many cities in our country

Images